drugset / Trial / NCT01406392
Sublingual Misoprostol for Induction of Labor
Phase 4
Completed
150 enrolled
Professor Fernando Figueira Integral Medicine Institute
Maternidade Escola Assis Chateaubriand · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare effectiveness and safety of a sublingual misoprostol 12,5 mcg with vaginal misoprostol 25 mcg for induction of labour with an alive and term fetus.
Timeline
- Start
- 2014-07-01
- Primary completion
- 2016-11-30
- Completion
- 2016-11-30
Publications
- Gattas DSMB, de Amorim MMR, Feitosa FEL, da Silva-Junior JR, Ribeiro LCG, Souza GFA, Souza ASR. Misoprostol administered sublingually at a dose of 12.5 mug versus vaginally at a dose of 25 mug for the induction of full-term labor: a randomized controlled trial. Reprod Health. 2020 Apr 10;17(1):47. doi: 10.1186/s12978-020-0901-8.
- Gattas DSMB, da Silva Junior JR, Souza ASR, Feitosa FE, de Amorim MMR. Misoprostol administered sublingually at a dose of 12.5 mug versus vaginally at a dose of 25 mug for the induction of full-term labor: a randomized controlled trial protocol. Reprod Health. 2018 Apr 18;15(1):65. doi: 10.1186/s12978-018-0508-5.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Misoprostol | Other / unclassified | 12.5 ug | Subcutaneous |
| Comparator | Misoprostol | Other / unclassified | 25 ug | Subcutaneous |
Indications
No indication recorded.